Interactome analysis implicates class II transactivator (CIITA) in depression and other neuroinflammatory disorders

Notwithstanding these limitations, the results presented here, could form a basis for further experimental studies to assess CIITA as a potential therapeutic target in managing depression and other neuroinflammatory disorders.